Cargando…
Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data col...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640028/ https://www.ncbi.nlm.nih.gov/pubmed/28993382 http://dx.doi.org/10.1136/bmjopen-2017-016546 |
_version_ | 1783270973497147392 |
---|---|
author | Aranaz Andrés, Jesus Maria Limón Ramírez, Ramon Aibar Remón, Carlos Gea-Velázquez de Castro, Maria Teresa Bolúmar, Francisco Hernández-Aguado, Ildefonso López Fresneña, Nieves Díaz-Agero Pérez, Cristina Terol García, Enrique Michel, Philippe Sousa, Paulo Larizgoitia Jauregui, Itziar |
author_facet | Aranaz Andrés, Jesus Maria Limón Ramírez, Ramon Aibar Remón, Carlos Gea-Velázquez de Castro, Maria Teresa Bolúmar, Francisco Hernández-Aguado, Ildefonso López Fresneña, Nieves Díaz-Agero Pérez, Cristina Terol García, Enrique Michel, Philippe Sousa, Paulo Larizgoitia Jauregui, Itziar |
author_sort | Aranaz Andrés, Jesus Maria |
collection | PubMed |
description | BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs. OBJECTIVES: The aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design. SETTING: Secondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru. PARTICIPANTS: The IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population. METHODS: This study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study. RESULTS: The prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk. CONCLUSION: The retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design. |
format | Online Article Text |
id | pubmed-5640028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-56400282017-10-19 Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design Aranaz Andrés, Jesus Maria Limón Ramírez, Ramon Aibar Remón, Carlos Gea-Velázquez de Castro, Maria Teresa Bolúmar, Francisco Hernández-Aguado, Ildefonso López Fresneña, Nieves Díaz-Agero Pérez, Cristina Terol García, Enrique Michel, Philippe Sousa, Paulo Larizgoitia Jauregui, Itziar BMJ Open Public Health BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs. OBJECTIVES: The aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design. SETTING: Secondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru. PARTICIPANTS: The IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population. METHODS: This study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study. RESULTS: The prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk. CONCLUSION: The retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design. BMJ Publishing Group 2017-10-08 /pmc/articles/PMC5640028/ /pubmed/28993382 http://dx.doi.org/10.1136/bmjopen-2017-016546 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Public Health Aranaz Andrés, Jesus Maria Limón Ramírez, Ramon Aibar Remón, Carlos Gea-Velázquez de Castro, Maria Teresa Bolúmar, Francisco Hernández-Aguado, Ildefonso López Fresneña, Nieves Díaz-Agero Pérez, Cristina Terol García, Enrique Michel, Philippe Sousa, Paulo Larizgoitia Jauregui, Itziar Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title | Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title_full | Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title_fullStr | Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title_full_unstemmed | Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title_short | Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design |
title_sort | comparison of two methods to estimate adverse events in the ibeas study (ibero-american study of adverse events): cross-sectional versus retrospective cohort design |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640028/ https://www.ncbi.nlm.nih.gov/pubmed/28993382 http://dx.doi.org/10.1136/bmjopen-2017-016546 |
work_keys_str_mv | AT aranazandresjesusmaria comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT limonramirezramon comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT aibarremoncarlos comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT geavelazquezdecastromariateresa comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT bolumarfrancisco comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT hernandezaguadoildefonso comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT lopezfresnenanieves comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT diazageroperezcristina comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT terolgarciaenrique comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT michelphilippe comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT sousapaulo comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign AT larizgoitiajaureguiitziar comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign |